Feed Preview

Multiple Sclerosis and Aging

Multiple Sclerosis and Aging diagram by Marvin 101, Wikimedia
Marvin 101, Wikimedia

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research MS and aging.

Top 20 most recent papers
Proceedings of the National Academy of Sciences of the United States of America

Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis

Proceedings of the National Academy of Sciences of the United States of AmericaOctober 24, 2019
Lindsay S CahillShannon E Dunn
6
6
The Journal of Immunology : Official Journal of the American Association of Immunologists

Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD- CD27- Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients

The Journal of Immunology : Official Journal of the American Association of ImmunologistsAugust 9, 2019
Judith FraussenVeerle Somers
10
9
Cell Stem Cell

Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells

Cell Stem CellOctober 5, 2019
Björn NeumannRobin J M Franklin
237
99
5
81
1
2
Annals of Neurology

Imaging Biomarkers of Alzheimer's Disease in Multiple Sclerosis

Annals of NeurologyJanuary 24, 2020
Burcu ZeydanKejal Kantarci
11
1
Annals of Neurology

Telomere Length Is Associated with Disability Progression in Multiple Sclerosis

Annals of NeurologySeptember 6, 2019
Kristen M KryskoJennifer S Graves
22
1
1
12
Autoimmunity Reviews

Pregnancy and multiple sclerosis: Clinical effects across the lifespan

Autoimmunity ReviewsAugust 12, 2019
Ai-Lan NguyenVilija G Jokubaitis
21
8
CNS Drugs

Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders

CNS DrugsSeptember 27, 2019
Niels BergslandRobert Zivadinov
6
1
2
5
Seminars in Cell & Developmental Biology

Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategies

Seminars in Cell & Developmental BiologyDecember 21, 2019
Yoshihide Asano, John Varga
2
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy

Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?

Diabetes, Metabolic Syndrome and Obesity : Targets and TherapyNovember 7, 2019
Piotr JareckiKatarzyna Lacka
1
3
Current Pharmaceutical Design

Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets

Current Pharmaceutical DesignNovember 14, 2019
Caterina Maria GambinoMarcello Ciaccio
1
2
Journal of Aging and Health

Goal Pursuit, Goal Adjustment, and Pain in Middle-Aged Adults Aging With Physical Disability

Journal of Aging and HealthNovember 14, 2019
Anne ArewasikpornIvan R Molton
1
Neuroscience and Biobehavioral Reviews

The need to incorporate aged animals into the preclinical modeling of neurological conditions

Neuroscience and Biobehavioral ReviewsDecember 27, 2019
Mujun SunSandy R Shultz
14
1
NeuroImage. Clinical

An improved algorithm of white matter hyperintensity detection in elderly adults

NeuroImage. ClinicalJanuary 14, 2020
T DingD L Tudorascu
9
Open Access Macedonian Journal of Medical Sciences

Echocardiographic Parameters Correlated with Age in Isolated Severe Rheumatic Mitral Stenosis Patients in Indonesia

Open Access Macedonian Journal of Medical SciencesAugust 29, 2019
Luh Oliva Saraswati Suastika, Amiliana Mardiani Soesanto
Frontiers in Molecular Neuroscience

Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells

Frontiers in Molecular NeuroscienceOctober 17, 2019
Charbel S BaakliniJason R Plemel
26
38

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis-and-aging/cce082e1-73b4-435d-b61a-42ded6bef250